Taichi Azuma

1.9k total citations
48 papers, 655 citations indexed

About

Taichi Azuma is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Taichi Azuma has authored 48 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Oncology and 12 papers in Immunology. Recurrent topics in Taichi Azuma's work include Chronic Lymphocytic Leukemia Research (7 papers), CAR-T cell therapy research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Taichi Azuma is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), CAR-T cell therapy research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Taichi Azuma collaborates with scholars based in Japan, United States and Canada. Taichi Azuma's co-authors include Masaki Yasukawa, Shigeru Fujita, Yoshihiro Yakushijin, Takaaki Hato, Kiyotaka Kuzushima, Hironari Niiya, Masanori Makita, Toshiki Ochi, Ikuya Sakai and Mine Harada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Taichi Azuma

45 papers receiving 641 citations

Peers

Taichi Azuma
Brian H. Santich United States
Sambasiva P. Rao United States
I D Bernstein United States
Michael Ehrhardt United States
Maaike Nederend Netherlands
Sonja Meixlsperger Germany
Giuliana Cassese Germany
Kana Washio Japan
N M Avdalovic United States
Roberta Guglielmino Italy
Brian H. Santich United States
Taichi Azuma
Citations per year, relative to Taichi Azuma Taichi Azuma (= 1×) peers Brian H. Santich

Countries citing papers authored by Taichi Azuma

Since Specialization
Citations

This map shows the geographic impact of Taichi Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taichi Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taichi Azuma more than expected).

Fields of papers citing papers by Taichi Azuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taichi Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taichi Azuma. The network helps show where Taichi Azuma may publish in the future.

Co-authorship network of co-authors of Taichi Azuma

This figure shows the co-authorship network connecting the top 25 collaborators of Taichi Azuma. A scholar is included among the top collaborators of Taichi Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taichi Azuma. Taichi Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochi, Toshiki, et al.. (2017). Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma. Blood. 130. 1913–1913. 4 indexed citations
2.
Yakushijin, Yoshihiro, Akihiro Tanaka, Taichi Azuma, et al.. (2013). Examination of the Appropriate Timing of Trimethoprim-sulfamethoxazole Administration for the Prevention of Pneumocystis Pneumonia in Patients with Malignant Lymphoma. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 39(8). 465–470. 1 indexed citations
3.
Yakushijin, Yoshihiro, et al.. (2013). Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP. International Journal of Clinical Oncology. 19(1). 178–185. 2 indexed citations
4.
An, Jun, Hiroshi Fujiwara, Koichiro Suemori, et al.. (2011). Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis. International Journal of Hematology. 93(2). 176–185. 8 indexed citations
5.
Yamanouchi, Jun, Takaaki Hato, Toshiyuki Niiya, et al.. (2011). A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia. International Journal of Hematology. 94(4). 395–398. 7 indexed citations
6.
Azuma, Taichi, Jun Yamanouchi, Masashi Kohno, et al.. (2010). Derivative (1;18)(q10;q10) in essential thrombocythemia. Cancer Genetics and Cytogenetics. 199(1). 62–64. 2 indexed citations
7.
Yakushijin, Yoshihiro, Kazuhito Takeuchi, Jun Yamanouchi, et al.. (2010). Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy. International Journal of Clinical Oncology. 16(2). 118–124. 5 indexed citations
8.
9.
Niiya, Hironari, Lei Jin, Taichi Azuma, et al.. (2006). Human herpesvirus 6 impairs differentiation of monocytes to dendritic cells. Experimental Hematology. 34(5). 642–653. 13 indexed citations
10.
Niiya, Hironari, Ikuya Sakai, Lei Jin, et al.. (2005). Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes. Experimental Hematology. 33(7). 811–818. 15 indexed citations
11.
Kojima, Kensuke, Ikuya Sakai, Atsuhiko Hasegawa, et al.. (2004). FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia. 18(5). 998–1005. 40 indexed citations
12.
Azuma, Taichi, Takemi Otsuki, Kiyotaka Kuzushima, et al.. (2004). Myeloma Cells Are Highly Sensitive to the Granule Exocytosis Pathway Mediated by WT1-Specific Cytotoxic T Lymphocytes. Clinical Cancer Research. 10(21). 7402–7412. 44 indexed citations
13.
14.
Makita, Masanori, Taichi Azuma, H Hamaguchi, et al.. (2002). Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes. Leukemia. 16(12). 2400–2407. 37 indexed citations
15.
Yasukawa, Masaki, et al.. (2002). Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes. European Journal Of Haematology. 69(2). 112–114. 13 indexed citations
16.
Azuma, Taichi, et al.. (2002). Identification of a novel WT1‐derived peptide which induces human leucocyte antigen‐A24‐restricted anti‐leukaemia cytotoxic T lymphocytes. British Journal of Haematology. 116(3). 601–603. 50 indexed citations
17.
Kojima, Kensuke, Eijiro Omoto, Masamichi Hara, et al.. (1998). Myelodysplastic syndrome with translocation (8; 21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?. Annals of Hematology. 76(6). 279–282. 15 indexed citations
18.
Kojima, Kensuke, et al.. (1998). Deleted HTLV provirus in peripheral blood cells of a patient with T‐cell prolymphocytic leukaemia. British Journal of Haematology. 100(3). 567–570. 4 indexed citations
19.
Mochizuki, Masami, et al.. (1992). Serotype 2 Reoviruses from the Feces of Cats with and without Diarrhea.. Journal of Veterinary Medical Science. 54(5). 963–968. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian H. Santich Breakdown of academic impact, for papers by Sambasiva P. Rao Breakdown of academic impact, for papers by I D Bernstein Breakdown of academic impact, for papers by Michael Ehrhardt Breakdown of academic impact, for papers by Maaike Nederend Breakdown of academic impact, for papers by Sonja Meixlsperger Breakdown of academic impact, for papers by Giuliana Cassese Breakdown of academic impact, for papers by Kana Washio Breakdown of academic impact, for papers by N M Avdalovic Breakdown of academic impact, for papers by Roberta Guglielmino
Rankless by CCL
2026